Zynnon (www.zynnon.com) is a start-up focused on improving and protecting people’s health using the Internet of Medical Things (IoMT). Zynnon is developing Lieberty, an innovative non-contact multi-parametric sensor combining health and environmental parameters. It is used to analyse indoor spaces in order to evaluate the risk of respiratory infections. The hardware is used in conjunction with our cloud-based artificial intelligence solution, which generates a Risk of Infection Index and provides alerts as well as recommendations for corrective action.
This hardware and cloud solution provides key information for families, offering insights into older relatives’ living conditions, for example, so that they can make adjustments and act faster in the event of an alert. It helps older people to improve their health and safety in the home through the early detection of respiratory infection risks. This is also a valuable solution for care homes, where it can stop respiratory infections from spreading thanks to the early detection of risks in indoor spaces.
Location: Switzerland, Schwyz, Schindellegi
Employees: 1-10
Total raised: $834.829K
Founded date: 2019
Funding Rounds 1
| Date | Series | Amount | Investors | Deal News |
| 27.06.2022 | - | $834.829K | - | startuptic... |
Mentions in press and media 3
| Date | Title | Description | Source |
| 13.09.2023 | Zynnon's Clinical Study Yields Promising Results | Respiratory infections pose a significant challenge in healthcare, often leading to misdiagnoses, ... | startuptic... |
| 27.06.2022 | Zynnon raises CHF800,000 to lower the risk of respiratory in... | Hospital-acquired infections have long been one of the most serious risks for patients, especially... | startuptic... |
| 07.06.2022 | Four start-ups secure funding for their innovation projects | Within the framework of the national innovation projects, Innosuisse covers the costs of the resea... | startuptic... |